Glow GHK-CU

Glow GHK-CU peptide injection is a formulation that may acts as a copper carrier and gene signaling peptide. It can be used in dealing with tissue repair, anti-inflammation, antioxidant defense and angiogenesis. GHK-CU refers to Glycyl-Histidyl -Lysine and Copper, which is a natural tripeptide-copper complex found in human plasma.

Key Features

About
Drug Class	Dermal regenerative agent
Subclass	Tissue remodeling/ Wound healing peptide
Active ingredient	GHK-CU (Glycyl-L-Histidyl-Lysine Copper)

Glow GHK-CU peptide injection
Composition	Active ingredients GHK-CU (Glycyl-L-Histidyl-Lysine Copper) Inactive ingredients: Acetic acid Mannitol Phosphate buffer
Packaging Type	Sterile glass vial
Pack Size	1 Pen or vial
Dosage	70 mg
Active ingredients	GHK-CU (Glycyl-L-Histidyl-Lysine Copper)
Manufacturer	Alluvi Healthcare
Shelf Life	Two years refrigerated for unopened pens.
Usages	Tissue repair, anti-inflammation, antioxidant defense and angiogenesis.
Country of Origin	India

How does GHK-CU Peptide injection work?  

• It may bind to Cu2+ tightly, transports it into cells. Copper is a cofactor for lysyl oxidase, superoxide dismutase, cytochrome c oxidase. This may support collagen and elastin crosslinking, antioxidant defense and mitochondrial energy.
• Gene expression modulation, GHK-CU may regulate approx. 4000 human genes. Followed by tissue remodeling, wound healing, anti-inflammatory, antioxidant and anti-fibrotic and anticancer.

Usage

• It can be used in wound healing.
• Joint and tendon repair.
• It can be used in skin tightening.
• Reduce inflammation.

Dosage

• Starting dose can be 1 mg to assess tolerance.
• Do not exceed the dose by your own, consult a healthcare provider prior taking any such medications.

Side effects

• Nausea
• Vomiting
• Tremor
• Fatigue
• Abdominal pain
• Headache
• Redness
• Swelling

Interactions

• It may interact adversely with zinc supplements as high zinc may induce metallothionein.
• Long term copper excess can cause iron deficiency.
• NSAIDS steroids can blunt anti-inflammatory benefit.
• It may interact adversely with Penicillamine and Tetracyclines.
• It may interact with other copper containing products as it may increase risk of copper overload if combined. 

Pharmacokinetics

• Absorption: Approx. 50-100% SubQ but GHK-CU may chelate and bind tissue.
• Distribution: It may bind albumin and cell membranes. It may distribute to skin, liver, sites of inflammation/ injury.
• Metabolism: It is rapidly degraded by peptidases in pharma and tissue.
• Excretion: Peptide fragment via kidney. 

Precautions

• The one with prior medical condition of Wilson’s disease or copper metabolism disorder.
• In the condition of liver disease/ cirrhosis, kidney disease, active cancer or cancer history should avoid taking such medications.
• Pregnant and breast-feeding lady should avoid such medications.
• In the condition of hemochromatosis avoid using such meds.

Conclusion

Glow GHK-CU peptide injection is a formulation that may acts as a copper carrier and gene signaling peptide. It can be used in dealing with tissue repair, anti-inflammation, antioxidant defense and angiogenesis. GHK-CU refers to Glycyl-Histidyl -Lysine and Copper, which is a natural tripeptide-copper complex found in human plasma. It may show some side effects like nausea, vomiting, tremor, fatigue, abdominal pain, headache, redness and swelling. Consult a medical professional prior using any such medications.

FAQs

• For what purpose Glow GHK-CU peptide injection is used?
  Glow GHK-CU peptide injection can be used in dealing with tissue repair, anti-inflammation, antioxidant defense and angiogenesis.

• How does Glow GHK-CU peptide injection may work?
  Glow GHK-CU peptide injection works by bind to Cu2+ tightly, transports it into cells. Copper is a cofactor for lysyl oxidase, superoxide dismutase, cytochrome c oxidase. This may support collagen and elastin crosslinking, antioxidant defense and mitochondrial energy

• What can be the possible side effects of Glow GHK-CU peptide injection?
  The possible side effects of Glow GHK-CU peptide injections are nausea, vomiting, tremor, fatigue, abdominal pain, headache, redness and swelling.

• Who should avoid taking Glow GHK-CU peptide injection?
  The one with prior medical condition of Wilson’s disease or copper metabolism disorder, liver disease/ cirrhosis, kidney disease, active cancer or cancer history and pregnant and breast-feeding women should avoid taking such medications.

• What can be the onset of action of Glow GHK-CU peptide injection?
  The onset of action of Glow GHK-CU peptide injection can be approx. 0.5-1 hours in plasma.

Note: Glow GHK-CU peptide injection is a prescription medicine and this is for educational purpose only. Please prior using any such medications consult your healthcare provider.